Managers / Q1 2023 · view latest →
Aldebaran Capital, LLC
CIK 0001448430 · 10293 N. MERIDIAN STREET, SUITE 300, CARMEL, IN, 46290 · 317-818-7827
Summary
Aldebaran Capital, LLC reported $98M in U.S.-listed holdings across 34 positions for Q1 2023.
Its largest position, BRK/B, represents 14.9% of the portfolio.
Compared with Q4 2022, the fund opened 2 new positions and exited 2.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- Common Stock · 84.8% · $83M
- Other · 10.9% · $11M
- ETP · 3.9% · $4M
- Equity WRT · 0.4% · $368,467
Quarter-over-Quarter Changes full breakdown →
vs Q4 2022 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| GRPHGRAPHITE BIO INC | NEW | +130.0K | 130.0K | +$318,500 | $318,500 |
| CYTEIR THERAPEUTICS INC | NEW | +151.2K | 151.2K | +$275,255 | $275,255 |
| VOXXGUSDVOXX INTL CORP | SOLD OUT | −53.4K | 0 | −$447,283 | $0 |
| KBALUSDKIMBALL INTL INC | SOLD OUT | −30.4K | 0 | −$197,925 | $0 |
| PATKPATRICK INDS INC | TRIMMED | −6.2K | 14.3K | −$259,633 | $986,667 |
| CHVCHEVRON CORP NEW | ADDED | +6.8K | 32.5K | +$690,606 | $5M |
| CO2ACATO CORP NEW | ADDED | +68.1K | 633.8K | +$325,130 | $6M |
| IESCIES HLDGS INC | HELD | −250 | 5.9K | +$35,145 | $252,335 |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q1 2023
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q1 2026 | $131M | 43 | May 7, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q4 2025 | $112M | 35 | Feb 12, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q3 2025 | $109M | 33 | Nov 10, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | $101M | 34 | Aug 12, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q1 2025 | $106M | 41 | May 13, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $105M | 37 | Feb 12, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $110M | 37 | Nov 13, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $107M | 36 | Aug 13, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $105M | 33 | May 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $98M | 31 | Feb 13, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $98M | 33 | Nov 13, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $97M | 33 | Aug 9, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $98M | 34 | May 11, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $97M | 34 | Feb 13, 2023 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.